Document is current
Any future updates will be listed below
-
Authors
Bejerot, Susanne
Eklund, Daniel
Hesser, Hugo
Hietala, Max Albert
Kariis, Tarmo
Lange, Niclas
Lebedev, Alexander
Montgomery, Scott
Nordenskjöld, Axel
Petrovic, Predrag
Söderbergh, Annika
Thunberg, Per
Wikström, Sverre
Humble, Mats B.
,
Asellus, Peter
Bergman-Nordgren, Lise
Bylund, Simon
Eberhard, Jonas
Figueras Diaz, Clara
Jacobson, Karin
Lindeborg, Erica
Lowert, Yvonne
Nordström, Erik
Terstad Ollén, David
-
Funding
Funding for this research was provided by:
The Swedish Brain Foundation (FO2022-0073)
Torsten Söderberg Foundation (MT4/22)
The Swedish Research Council (2022-00288)
Örebro University
- License Information
-
More Information
Article History
Received: 22 September 2023
Accepted: 3 October 2023
First Online: 23 October 2023
Declarations
:
: This study was approved by the Swedish Ethical Review Authority, file number 2022–03827-01 on the 10<sup>th</sup> of August 2022. Before enrolment written informed consent is obtained from each patient.
: Not applicable.
: Dr. Nordenskjöld reported receiving lecture honoraria from Lundbeck outside the submitted work. Dr Montgomery reported receiving grants from Merck, Novartis, and AstraZeneca and personal fees from Tiva and Merck outside the submitted work. Susanne Bejerot, Daniel Eklund, Hugo Hesser, Max Albert Hietala, Tarmo Kariis, Niclas Lange, Alexander Lebedev, Predrag Petrovic, Annika Söderbergh, Per Thunberg, Sverre Wikström and Mats B. Humble declare no competing interests.
